VictorMangonaMD

PubMed

• Evolution of Proton Radiation Therapy Brainstem Constraints on the Pediatric Proton/Photon Consortium Registry.
  Dora Correia, Daniel J Indelicato, Arnold C Paulino, Ralph Ermoian, Stephen Mihalcik
  Practical Radiation Oncology. 2024-08-10
• Correction to: Radiotherapy for Atypical Teratoid/Rhabdoid Tumor (ATRT) on the Pediatric Proton/Photon Consortium Registry (PPCR).
  Andrew Roehrig, Daniel J Indelicato, Arnold C Paulino, Ralph Ermoian, William Hartsell
  Journal of Neuro-Oncology. 2023-08-01
• 1 citations
  Radiotherapy for Atypical Teratoid/Rhabdoid Tumor (ATRT) on the Pediatric Proton/Photon Consortium Registry (PPCR).
  Andrew Roehrig, Daniel J Indelicato, Arnold C Paulino, Ralph Ermoian, William Hartsell
  Journal of Neuro-Oncology. 2023-04-01

Journal Articles

• Toxicity After Central versus Peripheral Stereotactic Lung Radiotherapy (SBRT): A Propensity Score Matched-Pair Analysis  
  Mangona VS, Aneese AM, Hymas RV, Marina O, Ionascu D, Gallardo LJ, Yan D, Robertson JM, Grills IS, International Journal of Radiation Oncology Biology & Physics, 9/24/2014
• Evaluation of Image Guided Motion Management Methods in Lung Cancer Radiotherapy  
  Zhuang L, Yan D, Liang J, Ionascu D, Mangona V, Zhou J, Medical Physics, 1/1/2014
• Real-time catheter tracking for high-dose-rate prostate brachytherapy using an electromagnetic 3D-guidance device: A preliminary performance study  
  Zhou J, Sebastian E, Mangona V, Yan D, Medical Physics, 1/28/2013
• Lung Metastases Treated with Image-guided Stereotactic Body Radiation Therapy  
  Baschnagel A, Mangona V, Robertson J, Welsh R, Kestin L, Grills I, Clinical Oncology, 1/1/2013
• Outcomes after stereotactic lung radiotherapy or wedge resection for stage I non–small-cell lung cancer  
  Grills IS, Mangona VS, Welsh R, Chmielewski G, McInerney E, Martin S, et al, Journal of Clinical Oncology, 1/1/2010
• Join now to see all

Books/Book Chapters

• Positron Emission Tomography - Recent Developments in Instrumentation, Research and Clinical Oncological Practice 
  Chapter: “PET – Assessment of Oncologic Treatment Response 
  Page 191 - 223Grills, Inga S. and Mangona, Victor S.Editors: Dr. Sandro Misciagna.InTech2013
• Advances in Radiation Oncology in Lung Cancer 
  Chapter: Intensity-Modulated Radiation Therapy and Volumetric-Modulated Arc Therapy for Lung Cancer 
  Page 691 - 714Grills, Inga S. and Mangona, Victor SEditors: Jeremic B.Springer, Berlin - HeidelbergEdition 2,2011
• Positron Emission Tomography - Recent Developments in Instrumentation, Research and Clinical Oncological Practice 
  Chapter: PET – Assessment of Oncologic Treatment Response 
  Page 191 - 223Grills, Inga S. and Mangona, Victor SEditors: Sandro Misciagna.InTech2011

Abstracts/Posters

• Rate of 18FDG-PET Parameter Decline Early During Radiotherapy Predicts Clinical Outcomes in Locally-Advanced Non-Small Cell Lung Cancer (LA-NSCLC) - Oral Presentation
  Mangona VS, Kestin LL, Ionascu D, et al, RSNA 99th Scientific Assembly and Annual Meeting, Chicago, IL, 12/1/2013
• Recurrence, Survival, and Toxicity after Stereotactic Lung Radiotherapy (SBRT) for Central versus Peripheral Stage I Non-Small Cell Lung Cancer (NSCLC): Results from a...
  Grills IS, Mangona VS, Hope, A; Belderbos J; Werner-Wasik M; Sonke J-J; Bissonette J-P, Ionascu D, Xiao Y, Toussaint A, Guckenberger M, IASLC 15th World Conference on Lung Cancer, Sydney, Australia, 10/27/2013
• TCP modeling in Stereotactic Body Radiotherapy for early stage non small cell lung cancer: is a dose-volume effect present? - Oral Presentation
  Peulen H, Belderbos J, Grills IS, Hope A, Guckenberger M, Werner-Wasik M, Mangona VS, Xiao Y, Toussaint A, Bissonnette J-P, Yan D, Sonke J-J, IASLC 15th World Conference on Lung Cancer, Sydney, Australia, 10/27/2013
• Predictors of Chest Wall and Extrapulmonary Soft Tissue Toxicity After Stereotactic Lung Radiotherapy: A Dosimetric Analysis - Oral Presentation
  Mangona VS, Grills IS, Lindamood K, Schulze D, Aneese AM, Ionascu D, Marina O, Robertson JM, Yan D, ASTRO Annual Meeting, Atlanta, GA, 9/22/2013
• Clinical Outcomes After Central versus Peripheral Stereotactic Lung Radiotherapy (SBRT): A Propensity Score Matched-Pair Analysis - Poster
  Mangona VS, Aneese AM, Hymas RV, Stromberg D, Ionascu D, Yan D, Grills IS, ASTRO Annual Meeting, Atlanta, GA, 9/22/2013
• A Matched Pair Analysis of Stage I Non-Small Cell Lung Cancer Treated with Lobectomy, Stereotactic Radiotherapy (SBRT), or Wedge Resection - Oral Presentation
  Hymas RV, Mangona VS, Welsh R, Chmielewski G, Aneese AM, Marina O, Baschnagel AM, Gustafson BR, Deraniyagala R, Grills IS, ASTRO Annual Meeting, Atlanta, GA, 9/22/2013
• Toxicity After Central versus Peripheral Stereotactic Lung Radiotherapy (SBRT): A Propensity Score Matched-Pair Analysis - Oral Presentation
  Aneese AM, Mangona VS, Hymas RV, Marina O, Ionascu D, Gallardo LJ, Yan D, Robertson JM, Grills IS, ASTRO Annual Meeting, Atlanta, GA, 9/22/2013
• Prospective Phase II Trial of Moderate Dose Image-guided Stereotactic Lung Radiotherapy (SBRT) for Early Stage Non-small cell lung cancer (NSCLC) and Pulmonary Metasta...
  Grills IS, Mangona VS, Aneese AM, Hymas RV, Marina O, Kestin LL, Lurie M, Yan D, ASTRO Annual Meeting, Atlanta, GA, 9/22/2013
• A Dosimetric Evaluation of Target Coverage as a Predictor of Local Failure Following Stereotactic Body Radiation Therapy for Spinal Tumors - Poster
  Jawad MS, Ionascu D, Zhou J, Harb JG, Wloch J, Mangona VS, et al, ASTRO Annual Meeting, Atlanta, GA, 9/22/2013
• Early 18FDG-PET SUV Kinetics During Radiotherapy Predict Clinical Outcome in Locally- Advanced Non-Small Cell Lung Cancer (LA-NSCLC) - Oral Presentation
  Mangona VS, Kestin LL, Ionascu D, et al, 43rd Annual Beaumont Health System Residents and Fellows Research Forum, Royal Oak, MI, 6/5/2013
• A Dosimetric Evaluation of Target Coverage as a Predictor of Local Failure Following Stereotactic Body Radiation Therapy for Spinal Tumors - Oral Presentation
  Jawad MS, Ionascu D, Zhou J, Harb JG, Wloch J, Mangona VS, et al, 43rd Annual Beaumont Health System Residents and Fellows Research Forum, Royal Oak, MI, 6/5/2013
• Early 18FDG-PET SUV Kinetics During Radiotherapy Predict Clinical Outcome in Locally- Advanced Non-Small Cell Lung Cancer (LA-NSCLC) - Oral Presentation
  Mangona VS, Kestin LL, Ionascu D, et al, 35th Annual Southeast Michigan Continuing Medical Education (SEMCME) Research Forum, Rochester, MI, 5/22/2013
• Rate of 18FDG-PET Parameter Decline Early During Radiotherapy (RT) Predicts Clinical Outcomes in Locally-Advanced Non-Small Cell Lung Cancer (NSCLC)- Oral Presentation
  Mangona VS, Kestin LL, Ionascu D, et al, Michigan Radiological Society Radiation Oncology Resident Meeting, Novi, MI, 4/25/2013
• Boost Versus Monotherapy: A Propensity-Score Matched-Pair Analysis of High-Dose-Rate Brachytherapy with or without External Beam Radiotherapy for Low-and Intermediate-...
  Mangona VS, Marina O, Krauss DJ, et al, ABS Annual Meeting, New Orleans, LA, 4/18/2013
• Boost Versus Monotherapy: A Propensity-Score Matched-Pair Analysis of High-Dose-Rate Brachytherapy with or without External Beam Radiotherapy for Low-and Intermediate-...
  Mangona VS, Marina O, Krauss DJ, et al, Brachytherapy, 1/1/2013
• SUV Kinetics of Weekly 18FDG-PET During Radiation Therapy Predict Eventual Outcome in Locally-Advanced Non-small Cell Lung Cancer (NSCLC) - Oral Presentation
  Mangona VS, Kestin LL, Wong CO, et al, ASTRO Annual Meeting, Boston, MA, 10/28/2012
• Clinical Outcomes and Toxicity After Stereotactic Body Radiation Therapy (SBRT) With or Without Adjuvant Chemotherapy for Stage I Non-small Cell Lung Cancer (NSCLC) - ...
  Vance S, Ye H, Baschnagel A, Mangona V, et al, ASTRO Annual Meeting, Boston, MA, 10/28/2012
• Volumetric Analysis of FDG-PET Uptake After Local Recurrence Following Stereotactic Body Radiation Therapy for Early-stage Non-small Cell Lung Cancer - Oral Presentation
  Wilkinson JB, Grills I, Mangona V, et al, ASTRO Annual Meeting, Boston, MA, 10/28/2012
• Predictors of Local Recurrence After Stereotactic Body Radiation Therapy for Early-Stage Non-small Cell Lung Cancer
  Wilkinson JB, Mangona VS, Ionascu D, et al, ASTRO Annual Meeting, Boston, MA, 10/28/2012
• Can 18FDG-PET Predict Local Failure after Stereotactic Body Radiotherapy (SBRT) for Non-Small Cell Lung Cancer (NSCLC)? An Analysis of PET Kinetics - Oral Presentation
  Mangona VS, Kestin LL, Yan D, et al, ACRO Annual Meeting, Fort Meyers, FL, 2/23/2012
• Dose-Escalated 4D Image-Guided Radiotherapy (IGRT) for Non-Small Cell Lung Cancer (NSCLC): Early Outcomes and Toxicity
  McGee M, Grills I, Mangona V, et al, American Journal of Clinical Oncology - Cancer Clinical Trials, 1/1/2012
• Clinical Outcomes and Toxicity After Stereotactic Body Radiation Therapy (SBRT) With or Without Adjuvant Chemotherapy for Stage I Non-small Cell Lung Cancer (NSCLC)
  Vance S, Ye H, Baschnagel A, Mangona V, et al, Int J Radiat Oncol Biol Phys, 1/1/2012
• Predictors of Local Recurrence After Stereotactic Body Radiation Therapy for Early-Stage Non-small Cell Lung Cancer
  Wilkinson JB, Mangona VS, Ionascu D, et al, Int J Radiat Oncol Biol Phys, 1/1/2012
• Can 18FDG-PET Predict Local Failure after Stereotactic Body Radiotherapy (SBRT) for Non-Small Cell Lung Cancer (NSCLC)? An Analysis of PET Kinetics
  Mangona VS, Kestin LL, Yan D, et al, American Journal of Clinical Oncology, 1/1/2012
• SUV Kinetics of Weekly 18FDG-PET During Radiation Therapy Predict Eventual Outcome in Locally-Advanced Non-small Cell Lung Cancer (NSCLC)
  Mangona VS, Kestin LL, Wong CO, et al, Int J Radiat Oncol Biol Phys, 1/1/2012
• Join now to see all